» Articles » PMID: 24235140

Bacteriocin Protein BacL1 of Enterococcus Faecalis is a Peptidoglycan D-isoglutamyl-L-lysine Endopeptidase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Nov 16
PMID 24235140
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Enterococcus faecalis strains are commensal bacteria in humans and other animals, and they are also the causative agent of opportunistic infectious diseases. Bacteriocin 41 (Bac41) is produced by certain E. faecalis clinical isolates, and it is active against other E. faecalis strains. Our genetic analyses demonstrated that the extracellular products of the bacL1 and bacA genes, which are encoded in the Bac41 operon, coordinately express the bacteriocin activity against E. faecalis. In this study, we investigated the molecular functions of the BacL1 and BacA proteins. Immunoblotting and N-terminal amino acid sequence analysis revealed that BacL1 and BacA are secreted without any processing. The coincidental treatment with the recombinant BacL1 and BacA showed complete bacteriocin activity against E. faecalis, but neither BacL1 nor BacA protein alone showed the bacteriocin activity. Interestingly, BacL1 alone demonstrated substantial degrading activity against the cell wall fraction of E. faecalis in the absence of BacA. Furthermore, MALDI-TOF MS analysis revealed that BacL1 has a peptidoglycan D-isoglutamyl-L-lysine endopeptidase activity via a NlpC/P60 homology domain. These results collectively suggest that BacL1 serves as a peptidoglycan hydrolase and, when BacA is present, results in the lysis of viable E. faecalis cells.

Citing Articles

Comprehensive analysis of bacteriocins produced by clinical enterococcal isolates and their antibacterial activity against Enterococci including VRE.

Fujii A, Kawada-Matsuo M, Le M, Suzuki Y, Nishihama S, Shiba H Sci Rep. 2025; 15(1):4846.

PMID: 39924578 PMC: 11808071. DOI: 10.1038/s41598-025-89518-8.


The lactococcal ICE-ome encodes a repertoire of exchangeable traits with potential industrial relevance.

van der Els S, Boekhorst J, Bron P, Kleerebezem M BMC Genomics. 2024; 25(1):734.

PMID: 39080539 PMC: 11288074. DOI: 10.1186/s12864-024-10646-y.


Construction and Activity Testing of a Modular Fusion Peptide against .

Manoharadas S, Altaf M, Ahmad N, Alrefaei A, Al-Rayes B Antibiotics (Basel). 2023; 12(2).

PMID: 36830298 PMC: 9951850. DOI: 10.3390/antibiotics12020388.


Inactivation of GalU Leads to a Cell Wall-Associated Polysaccharide Defect That Reduces the Susceptibility of Enterococcus faecalis to Bacteriolytic Agents.

Kurushima J, Tomita H Appl Environ Microbiol. 2021; 87(7).

PMID: 33483312 PMC: 8091619. DOI: 10.1128/AEM.02875-20.


Targeting the Achilles' Heel of Bacteria: Different Mechanisms To Break Down the Peptidoglycan Cell Wall during Bacterial Warfare.

Sibinelli-Sousa S, Hespanhol J, Bayer-Santos E J Bacteriol. 2020; 203(7).

PMID: 33139480 PMC: 8088523. DOI: 10.1128/JB.00478-20.


References
1.
Eckert C, Lecerf M, Dubost L, Arthur M, Mesnage S . Functional analysis of AtlA, the major N-acetylglucosaminidase of Enterococcus faecalis. J Bacteriol. 2006; 188(24):8513-9. PMC: 1698247. DOI: 10.1128/JB.01145-06. View

2.
Franz C, van Belkum M, Holzapfel W, Abriouel H, Galvez A . Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiol Rev. 2007; 31(3):293-310. DOI: 10.1111/j.1574-6976.2007.00064.x. View

3.
Schneewind O, Missiakas D . Protein secretion and surface display in Gram-positive bacteria. Philos Trans R Soc Lond B Biol Sci. 2012; 367(1592):1123-39. PMC: 3297441. DOI: 10.1098/rstb.2011.0210. View

4.
Arai R, Fukui S, Kobayashi N, Sekiguchi J . Solution structure of IseA, an inhibitor protein of DL-endopeptidases from Bacillus subtilis, reveals a novel fold with a characteristic inhibitory loop. J Biol Chem. 2012; 287(53):44736-48. PMC: 3531787. DOI: 10.1074/jbc.M112.414763. View

5.
Tettelin H, Masignani V, Cieslewicz M, Eisen J, Peterson S, Wessels M . Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A. 2002; 99(19):12391-6. PMC: 129455. DOI: 10.1073/pnas.182380799. View